Cargando…

Upregulation of Ganglioside GD2 Synthase (GD2S), as a New Putative Cancer Stem Cell Marker in Breast Carcinomas

Background: GD2 synthase (GD2S) is the key enzyme required for ganglioside GD2 synthesis. It is commonly expressed in normal tissues and various cancers. Ganglioside GD2 is identified as a breast cancer stem cells (BCSCs) marker that promotes tumorigenesis. As GD2S has been found to be a useful mole...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mansoori, Maryam, Mirzaei, Alireza, Abdi Rad, Isa, Mahmodlou, Rahim, Mansouri, Fatemeh, Saeednejad Zanjani, Leili, Asadi- Lari, Zeynab, Madjd, Zahra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Iran University of Medical Sciences 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840866/ https://www.ncbi.nlm.nih.gov/pubmed/35321364 http://dx.doi.org/10.47176/mjiri.35.148

Ejemplares similares

Ganglioside GD3 synthase (GD3S), a novel cancer drug target
por: Liu, Jinyi, et al.
Publicado: (2018)

The biological role and immunotherapy of gangliosides and GD3 synthase in cancers
por: Cao, Shangqi, et al.
Publicado: (2023)

GD3- and O-acetylated GD3-gangliosides in the GM2 synthase-deficient mouse brain and their immunohistochemical localization
por: Matsuda, Junko, et al.
Publicado: (2006)

Expression of GD2 and GD3 gangliosides in human embryonic neural stem cells
por: Yanagisawa, Makoto, et al.
Publicado: (2011)

Disordered testosterone transport in mice lacking the ganglioside GM2/GD2 synthase gene
por: Furukawa, Koichi, et al.
Publicado: (2023)

Biology of GD2 ganglioside: implications for cancer immunotherapy
por: Machy, Pierre, et al.
Publicado: (2023)

GD2 and GD3 gangliosides as diagnostic biomarkers for all stages and subtypes of epithelial ovarian cancer
por: Galan, Alba, et al.
Publicado: (2023)

Targeting O-Acetyl-GD2 Ganglioside for Cancer Immunotherapy
por: Fleurence, Julien, et al.
Publicado: (2017)

Alterations in neuroblastoma ganglioside synthesis by induction of GD1b synthase by retinoic acid
por: Hettmer, S, et al.
Publicado: (2004)

GD2 and GD3 synthase: novel drug targets for cancer therapy
por: Sphyris, Nathalie, et al.
Publicado: (2015)

Acetylation Suppresses the Proapoptotic Activity of GD3 Ganglioside
por: Malisan, Florence, et al.
Publicado: (2002)

Human melanoma antigen AH is an autoantigenic ganglioside related to GD2
Publicado: (1982)

Ganglioside GD2 expression is maintained upon recurrence in patients with osteosarcoma
por: Poon, Vincent I, et al.
Publicado: (2015)

Overexpression and translocation of dynamin 2 promotes tumor aggressiveness in breast carcinomas
por: Sajed, Roya, et al.
Publicado: (2020)

Extracellular vesicles released from ganglioside GD2-expressing melanoma cells enhance the malignant properties of GD2-negative melanomas
por: Yesmin, Farhana, et al.
Publicado: (2023)

Ganglioside GD2 in reception and transduction of cell death signal in tumor cells
por: Doronin, Igor I, et al.
Publicado: (2014)

Targeting and killing glioblastoma with monoclonal antibody to O-acetyl GD2 ganglioside
por: Fleurence, Julien, et al.
Publicado: (2016)

RNA Sequencing-Based Identification of Ganglioside GD2-Positive Cancer Phenotype
por: Sorokin, Maxim, et al.
Publicado: (2020)

Ganglioside GD2 Enhances the Malignant Phenotypes of Melanoma Cells by Cooperating with Integrins
por: Yesmin, Farhana, et al.
Publicado: (2021)

Co-expression of cancer stem cell markers, SALL4/ALDH1A1, is associated with tumor aggressiveness and poor survival in patients with serous ovarian carcinoma
por: Sharbatoghli, Mina, et al.
Publicado: (2022)

Expression of ganglioside GD2, reprogram the lipid metabolism and EMT phenotype in bladder cancer
por: Vantaku, Venkatrao, et al.
Publicado: (2017)

A Monoclonal Antibody to O-Acetyl-GD2 Ganglioside and Not to GD2 Shows Potent Anti-Tumor Activity without Peripheral Nervous System Cross-Reactivity
por: Alvarez-Rueda, Nidia, et al.
Publicado: (2011)

Correction: Expression of ganglioside GD2, reprogram the lipid metabolism and EMT phenotype in bladder cancer
por: Vantaku, Venkatrao, et al.
Publicado: (2019)

Longitudinal Evolution of the Concentration of Gangliosides GM3 and GD3 in Human Milk
por: Giuffrida, Francesca, et al.
Publicado: (2014)

The Association Between Higher Expression of Talin-1 and the Reduced Survival Rate in Ovarian Serous Carcinoma Patients
por: Sharbatoghli, Mina, et al.
Publicado: (2023)

The Effect of GD1a Ganglioside-Expressing Bacterial Strains on Murine Norovirus Infectivity
por: Zhu, Yifan, et al.
Publicado: (2020)

Ganglioside GD3 regulates neural stem cell quiescence and controls postnatal neurogenesis
por: Fuchigami, Takahiro, et al.
Publicado: (2023)

Disruption of GM2/GD2 synthase gene resulted in overt expression of 9-O-acetyl GD3 irrespective of Tis211
por: Furukawa, Keiko, et al.
Publicado: (2008)

Digital TDPAC with rare earth isotope $^{169}$Yb, $^{147}$Gd, and $^{149}$Gd in Yb and Gd Doped CeO$_{2}$ and $^{147}$Gd in GdBa$_{2}$ Cu$_{3}$ O$_{7−\delta}$
por: Roeder, Jens, et al.
Publicado: (2011)

Brain gangliosides of a transgenic mouse model of Alzheimer's disease with deficiency in GD3-synthase: expression of elevated levels of a cholinergic-specific ganglioside, GT1aα
por: Ariga, Toshio, et al.
Publicado: (2013)

Role of Sialyl-O-Acetyltransferase CASD1 on GD2 Ganglioside O-Acetylation in Breast Cancer Cells
por: Cavdarli, Sumeyye, et al.
Publicado: (2021)

TNFα-signal and cAMP-mediated signals oppositely regulate melanoma- associated ganglioside GD3 synthase gene in human melanocytes
por: Takeuchi, Rika, et al.
Publicado: (2019)

GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody
Publicado: (1982)

Prevalence of IgG Autoantibodies against GD3 Ganglioside in Acute Zika Virus Infection
por: Nico, Dirlei, et al.
Publicado: (2018)

Upregulation of cell surface GD3 ganglioside phenotype is associated with human melanoma brain metastasis
por: Ramos, Romela Irene, et al.
Publicado: (2020)

Co-expression of Cancer Stem Cell Markers OCT4 and NANOG Predicts Poor Prognosis in Renal Cell Carcinomas
por: Rasti, Arezoo, et al.
Publicado: (2018)

Clinical and prognostic significances of cancer stem cell markers in gastric cancer patients: a systematic review and meta-analysis
por: Razmi, Mahdieh, et al.
Publicado: (2021)

Monoclonal antibody 3F8 recognises the neural cell adhesion molecule (NCAM) in addition to the ganglioside GD2.
por: Patel, K., et al.
Publicado: (1989)

Ganglioside GD2-specific trifunctional surrogate antibody Surek demonstrates therapeutic activity in a mouse melanoma model
por: Ruf, Peter, et al.
Publicado: (2012)

Porcine Sapelovirus Uses α2,3-Linked Sialic Acid on GD1a Ganglioside as a Receptor
por: Kim, Deok-Song, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_tf73bdhplc23qd95uhjv5858pr